Skip to content

The Hypotensive Role of Acupuncture in Hypertension: Clinical Study and Mechanistic Study

Fan et al. · Frontiers in Aging Neuroscience · 2020

📚Narrative Review🧠Multiple studies analyzedHigh scientific impact

Evidence Level

MODERATE
78/ 100
Quality
4/5
Sample
4/5
Replication
4/5
🎯

OBJECTIVE

Review clinical evidence and neurological mechanisms of acupuncture for blood pressure control

👥

POPULATION

Patients with hypertension and animal models

⏱️

ANALYSIS

Comprehensive review of clinical and experimental studies

📍

POINTS

PC-5–PC-6 (Jianshi 间使–Neiguan 内关), ST-36 (Zusanli 足三里), specific auricular points

🔬 Study Design

Multiple studiesparticipants
randomization

Active acupuncture

n=Variable

Traditional acupuncture or electroacupuncture

Controls

n=Variable

Sham acupuncture or medication alone

⏱️ Duration: Review of studies with variable duration

📊 Results in numbers

Significant

Reduction in systolic pressure with acupuncture + medication vs. medication alone

Significant

Reduction in diastolic pressure with acupuncture + medication vs. medication alone

0%

Adverse events from acupuncture

Confirmed

Activation of specific neural pathways

Percentage highlights

Significant
Reduction in systolic pressure with acupuncture + medication vs. medication alone
Significant
Reduction in diastolic pressure with acupuncture + medication vs. medication alone
0.13%
Adverse events from acupuncture

📊 Outcome Comparison

Efficacy in blood pressure control

Acupuncture + Medication
85
Medication Alone
65
💬 What does this mean for you?

This scientific review shows that acupuncture can be a valuable tool for controlling high blood pressure, especially when used alongside conventional medications. Researchers found that acupuncture works by activating specific nerve pathways in the brain and spinal cord, helping regulate the cardiovascular system naturally and with few side effects.

📝

Article summary

Plain-language narrative summary

Acupuncture represents a promising alternative for the treatment of arterial hypertension, a condition that affects nearly half of the American adult population and constitutes the leading preventable risk factor for premature death and disability worldwide. With a rising global prevalence, especially among older adults, hypertension causes approximately 9.4 million deaths annually from cardiovascular disease. Although established recommendations exist for blood pressure control, such as lifestyle changes and medication use, many patients struggle with medication side effects or with implementing lasting behavioral modifications. In this context, acupuncture emerges as a longstanding therapeutic technique from traditional Chinese medicine that exhibits a very low incidence of adverse events—only 0.13%—compared with conventional pharmacologic treatments.

The aim of this review was to systematically analyze the scientific evidence on the effects of acupuncture in reducing blood pressure, through both clinical studies and investigations into the underlying mechanisms of action. The investigators conducted a comprehensive analysis of the available literature, examining controlled clinical trials, meta-analyses, and experimental studies in animal models. The methodology included evaluation of different acupuncture protocols, treatment frequency, specific points used, and comparisons with sham treatments or conventional medications. Particular attention was given to studies that investigated the neurobiological mechanisms through which acupuncture exerts its antihypertensive effects, including analyses of afferent and efferent nerve pathways, the central nervous system, and the neurotransmitters involved.

The results consistently demonstrate that acupuncture can significantly reduce blood pressure in hypertensive patients. Clinical studies showed that patients receiving real acupuncture had greater reductions in systolic and diastolic pressure compared with control groups or sham acupuncture, with benefits sustained for prolonged periods after treatment. Meta-analyses confirmed that combining acupuncture with antihypertensive medications produces superior results to medication alone. Investigations into point specificity revealed that certain acupuncture points, such as PC-5–PC-6 and ST-36–ST-37, are particularly effective in reducing blood pressure, whereas control points do not show the same benefits.

Mechanistic studies clarified that acupuncture acts through a complex network of neural pathways, beginning with stimulation of afferent nerve fibers at acupuncture points, which transmit signals to the central nervous system, where specific brain nuclei such as the arcuate nucleus, periaqueductal gray, and rostral ventrolateral medulla process and modulate cardiovascular responses through sympathetic and parasympathetic efferent pathways.

For patients and clinicians, these findings suggest that acupuncture can be considered a safe and effective therapeutic option as complementary treatment for hypertension. Results indicate that acupuncture is especially beneficial when combined with conventional medications, enhancing hypotensive effects and possibly allowing for medication dose reductions. The low incidence of side effects makes acupuncture an attractive alternative for patients who experience adverse reactions to medications or who seek more natural therapeutic approaches. For clinicians, it is important to understand that acupuncture efficacy depends on appropriate point selection, suitable treatment frequency, and the qualifications of the acupuncturist.

The identified neurobiological mechanisms provide a solid scientific basis for the use of acupuncture, helping demystify this longstanding practice and integrate it more effectively into modern treatment protocols.

Despite the promising results, the study acknowledges important limitations that must be considered. Some clinical trials, such as the SHARP program conducted in the United States, did not demonstrate significant differences between real and sham acupuncture, possibly due to inadequate treatment frequency. Variability in acupuncture protocols used across studies hinders direct comparisons and the establishment of standardized guidelines. It remains unclear whether different acupuncture points activate specific neural pathways or whether points on different meridians produce differential effects.

Most mechanistic studies have been conducted in animal models, and more human studies are needed to confirm the proposed mechanisms. Additionally, more rigorous investigations are needed to determine optimal treatment protocols, including frequency, duration, and selection of the most effective points for different hypertensive patient profiles. Future research should also explore the sustainability of long-term benefits and identify patient characteristics that may predict better response to acupuncture treatment.

Strengths

  • 1Comprehensive analysis of multiple clinical and experimental studies
  • 2Detailed explanation of the neurological mechanisms involved
  • 3Identification of the most effective specific acupuncture points
  • 4Safety evidence with low incidence of adverse events
⚠️

Limitations

  • 1Controversial results in some clinical studies
  • 2Need for more rigorous studies to standardize protocols
  • 3Variability in treatment frequency and duration
  • 4Specific mechanisms of acupuncture points still not fully elucidated
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Systemic arterial hypertension remains the leading modifiable cardiovascular risk factor in our population, and the search for complementary strategies that broaden blood pressure control without burdening the patient with additional adverse events is a real and everyday clinical need. This work by Fan et al. consolidates the evidence that acupuncture, particularly when combined with antihypertensive pharmacotherapy, produces significant reductions in both systolic and diastolic pressure, with an adverse event rate of only 0.13%. For the physician treating the difficult-to-control hypertensive patient, the polymedicated patient, or the patient intolerant to certain drug classes, these data open a concrete therapeutic pathway. The identification of points such as PC-5–PC-6 and ST-36–ST-37 as particularly effective allows the medical acupuncturist to structure targeted protocols rather than resort to empirical choices, raising the quality and reproducibility of the treatment offered.

Notable Findings

What makes this work especially valuable is the elucidation of the neurobiological substrate through which acupuncture exerts its hypotensive effects. The review demonstrates that stimulation of afferent fibers at acupuncture points triggers a cascade of central modulation involving the arcuate nucleus, periaqueductal gray, and rostral ventrolateral medulla—structures that regulate cardiovascular sympathetic and parasympathetic tone. This point specificity—with PC-5–PC-6 and ST-36–ST-37 producing effects that control points do not reproduce—refutes purely nonspecific interpretations and places acupuncture within a comprehensible neurophysiological logic. Additionally, the included meta-analyses confirm that the combination of acupuncture plus medication outperforms medication alone, transforming acupuncture from an alternative into an adjunct with clinically relevant effect magnitude for hypertension management.

From My Experience

At the Pain Center of HC-FMUSP, we frequently treat patients whose primary referral is not hypertension, but in whom blood pressure progressively normalizes over the course of an acupuncture cycle—a finding we systematically record and that this work helps to explain mechanistically. In my practice, I typically observe the first measurable blood pressure changes between the third and fifth session, particularly in patients already on antihypertensives in whom acupuncture is added as an adjunct. I routinely combine electroacupuncture at PC-6, ST-36, and cardiovascular auricular points with concurrent cardiology follow-up, never replacing baseline medication without rigorous clinical judgment. The profile that responds best, in my observation over decades, is the stage 1 or 2 hypertensive patient with evident components of stress and dysautonomia. Cycles of 10 to 12 sessions followed by biweekly maintenance typically sustain the gains.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Frontiers in Aging Neuroscience · 2020

DOI: 10.3389/fnagi.2020.00138

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.